ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:379-384. doi:10.1016/j.athoracsur.2007.09.011
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Chang Hyun Kang
Young Tae Kim
Joo Hyun Kim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, C. H.
Right arrow Articles by Kim, J. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kang, C. H.
Right arrow Articles by Kim, J. H.
Related Collections
Right arrow Mediastinum


Original Articles: General Thoracic

Surgical Treatment of Malignant Mediastinal Nonseminomatous Germ Cell Tumor

Chang Hyun Kang, MDa,*, Young Tae Kim, MDa, Sang-Hoon Jheon, MDb, Sook-whan Sung, MDb, Joo Hyun Kim, MDa

a Department of Thoracic and Cardiovascular Surgery, Cancer Research Institute, Seoul National University Hospital, Xenotransplantation Research Center, Clinical Research Institute, Seoul National University College of Medicine, Seoul, South Korea
b Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea

Accepted for publication September 10, 2007.

* Address correspondence to Dr Kang, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, 28 Yongon-dong, Chongro-gu, Seoul, 110-744, South Korea (Email: chkang{at}snu.ac.kr).

Background: The aim of this study was to evaluate the role of surgical treatment for mediastinal nonseminomatous germ cell tumors (MNSGCT) and identify the factors of long-term survival.

Methods: A retrospective review of the medical records of patients with primary MNSGCT who registered at our institute between 1988 and 2005 was performed. Of 29 patients who presented with primary MNSGCT, 21 patients (72.4%) underwent curative resection and were included in this study.

Results: All patients were male and symptomatic at presentation. Mean patient age was 24.4 years (range, 9 to 53 years). Three different regimens were used for preoperative chemotherapy, and 14 patients (66.7%) achieved partial response, 4 (19.0%) had stable disease, and 2 (9.5%) had progressive disease. Complete en bloc excision was possible in 16 patients (76.2%). The most common cause of incomplete resection was great vessel invasion (n = 3). Concomitantly resected organs were lung in 13 patients (61.9%) and superior vena cava in 5 (23.8%). Viable germ cell tumor was identified in pathology specimens in 12 (57.1%), total necrosis in 7 (33.3%), and remnant teratoma in 2 (9.5%). Five-year overall and disease-free survivals were 63.6% and 61.1%. Risk factors for poor overall survival by multivariate analysis were β-human chorionic gonadotrophin (β-HCG) elevation at initial diagnosis (p = 0.02) and incomplete resection (p = 0.002).

Conclusions: Surgical resection of MNSGCT after chemotherapy showed favorable long-term survival. Complete resection should be performed to achieve long-term survival. An elevated β-HCG level at initial diagnosis was associated with a poor prognosis despite multimodality therapy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.